Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of 2026-04-29, Terns Pharmaceuticals Inc. (TERN) trades at a current price of $52.92, marking a negligible -0.04% change from the prior session’s close. This analysis explores recent market context for the clinical-stage biopharmaceutical firm, key technical price levels, and potential near-term price scenarios, with no recently released earnings data available for the company as of this writing. Price action for TERN in recent weeks has been largely range-bound, driven primarily by broader h
What closed end fund Terns Pharmaceuticals (TERN)? (Motionless) 2026-04-29 - Real Time Stock Idea Network
TERN - Stock Analysis
3818 Comments
897 Likes
1
Ruelle
Influential Reader
2 hours ago
Indices are consolidating after recent gains, offering tactical entry points.
👍 262
Reply
2
Falisa
Active Reader
5 hours ago
This came at the wrong time for me.
👍 215
Reply
3
Maesynn
Consistent User
1 day ago
This feels illegal but I can’t explain why.
👍 23
Reply
4
Zoria
Active Contributor
1 day ago
US stock dividend safety analysis and payout ratio assessment for income sustainability evaluation and dividend investing decisions. We evaluate whether companies can maintain their dividend payments during economic downturns and challenging market conditions. We provide dividend safety scores, payout ratio analysis, and sustainability assessment for comprehensive coverage. Find sustainable income with our comprehensive dividend safety analysis and payout assessment tools for income investing.
👍 53
Reply
5
Broc
Legendary User
2 days ago
So disappointed I missed it. 😭
👍 293
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.